1 research outputs found
Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefit
10.1007/s00262-021-03075-3CANCER IMMUNOLOGY IMMUNOTHERAPY7161531-154
1 research outputs found